Bespoke Biotherapeutics
Bespoke Biotherapeutics: Innovating custom B-cell therapies for enhanced cancer immunotherapy.
Founded
2021Bespoke Biotherapeutics: Innovating custom B-cell therapies for enhanced cancer immunotherapy.
Bespoke Biotherapeutics, founded with a mission to revolutionize cancer treatment, specializes in engineered B-cell therapeutics. The company aims to enhance the natural immune response and address the limitations of existing immunotherapies. Their core services include customized B-cell sourcing, isolation, activation, culture expansion, and non-viral genetic engineering, all tailored to optimize commercial B-cell products for infusion. Bespoke Biotherapeutics is focused on the biotechnology market, particularly in the field of cancer immunotherapy.
Notable affiliated individuals include leading scientists and researchers in immunotherapy and genetic engineering. The company has garnered attention for its innovative approach and has been featured in prominent scientific publications such as Nature and Cancer Cell. Key achievements include advancements in CRISPR/Cas9 targeted nuclease technology for engineering primary human B-cells. Bespoke Biotherapeutics is making a significant impact by offering novel, customized living drugs that promise to improve the efficacy of cancer treatments.
Companies similar to Bespoke Biotherapeutics include Be Biopharma, Cellective BioTherapy, Cell BioEngines and Walking Fish Therapeutics.
Bespoke Biotherapeutics was founded in 2021.
Bespoke Biotherapeutics' headquarters is located in San Mateo, CA, US.
Bespoke Biotherapeutics' most recent funding round was for $256k (USD) in June 2022.
As of Jun 17, 2022, Bespoke Biotherapeutics has disclosed funding of $256k (USD). Undisclosed round amounts are excluded.
Bespoke Biotherapeutics has 2 employees as of Feb 4, 2024.
Walking Fish Therapeutics
